Cargando…
Renal Autologous Cell Therapy in Type 2 Diabetes with Late Stage 4 Diabetes-Related Chronic Kidney Disease: Trial Design and Early Analysis
INTRODUCTION: Cell-based therapies potentially delay the trajectory toward end-stage kidney disease (ESKD) in late stage 4 diabetic chronic kidney disease (DKD). We describe the trial design, baseline patient characteristics, and early results of an IRB-approved phase II multicenter clinical trial,...
Autores principales: | Stavas, Joseph, Thajudeen, Bijin, Coca, Steven, Silva, Arnold, Butler, Emily, Detwiler, Randal, Burgner, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932837/ https://www.ncbi.nlm.nih.gov/pubmed/36599315 http://dx.doi.org/10.1159/000527582 |
Ejemplares similares
-
Implantation of Autologous Selected Renal Cells in Diabetic Chronic Kidney Disease Stages 3 and 4—Clinical Experience of a “First in Human” Study
por: Stenvinkel, Peter, et al.
Publicado: (2016) -
Renal Autologous Cell Therapy to Stabilize Function in Diabetes-Related Chronic Kidney Disease: Corroboration of Mechanistic Action With Cell Marker Analysis
por: Stavas, Joseph, et al.
Publicado: (2022) -
Leukocyte Cell-Derived Chemotaxin 2-Associated Renal Amyloidosis: A Case Report
por: Kaur, Gagandeep, et al.
Publicado: (2017) -
Bilateral renal artery thrombosis secondary to acute necrotizing pancreatitis
por: Thajudeen, Bijin, et al.
Publicado: (2013) -
Outcome of Patients with Infective Endocarditis who were Treated with Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy
por: John, Santhosh G., et al.
Publicado: (2014)